Across nearly every state, the officials charged with enforcing the law have arrived at the same conclusion: a loophole written into federal agricultural policy has quietly become a pipeline for unregulated intoxicants, and children are paying the price. Thirty-nine attorneys general have formally asked Congress to close the gap left by the 2018 Farm Bill, which inadvertently permitted hemp-derived THC products to multiply beyond any meaningful oversight. The appeal is less a political maneuver than a reckoning — a moment when the distance between legislative intent and lived consequence has g
39 Attorneys General Urge Congress to Close Hemp THC Loopholes
Related Coverage
The UK government allocated nearly £10bn to build over 70,000 social and affordable homes across England over 10 years, …
BBC News · Aug 25 Hoy: Cancer screening push shouldn't fall to celebrities aloneOlympic cyclist Sir Chris Hoy argues that prostate cancer screening awareness should be a government responsibility, not…
The New York Times · Aug 25 Jelly Roll Marks 300-Pound Weight Loss With Trump Quip on KimmelCountry musician Jelly Roll marked a significant health achievement by losing 300 pounds, sharing the milestone while gu…
Al Jazeera · Aug 25 France and Saudi Arabia to jointly invest $7bn in three theme parks near ParisFrance and Saudi Arabia plan $7bn investment in three amusement parks near Paris, including a Dragon Ball Z-themed park …
Bias & Framing
Article frames hemp THC regulation as urgent public health crisis using alarming language about surging poison calls and ER visits, with limited counterargument representation.
Crisis framing with emphasis on harm to children and public safety concerns; positions regulatory action as necessary response to documented health threats
Geopolitical Impact
Domestic U.S. regulatory issue with no direct international implications; 39 AGs seek hemp THC restrictions due to public health concerns.
Economic Lens
39 state AGs urge Congress to close hemp THC loopholes amid rising poison control calls and pediatric ER visits, signaling potential regulatory tightening of the cannabis derivatives market.
Consumers may face reduced availability and higher prices for hemp-derived THC products; increased regulatory scrutiny could limit product variety and accessibility, particularly affecting those using these products for wellness purposes.
Likely federal legislation to regulate hemp-derived THC products more strictly; potential age verification requirements, potency limits, packaging standards, and labeling requirements; possible state-level bans preceding federal action; increased enforcement and compliance costs for industry.